Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can daily mindful breathing ease heart failure symptoms?

NCT ID NCT07824687

Symptom relief Sponsor: Ankara Medipol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are testing whether 20 minutes of mindful breathing each day for 8 weeks can reduce symptoms and improve clinical measures in people with heart failure. The trial enrolls 64 adults with NYHA stage II or III heart failure. Half practice mindful breathing with audio guidance and a mobile app, while the other half receive usual care. The study tracks symptom scores, cholesterol levels, and ejection fraction over 12 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mindful breathing meditation guided by audio recordings and a mobile app
What this could lead to
If it works, daily mindful breathing could become a low-cost, home-based way to help people with heart failure feel better and possibly improve some heart and cholesterol measures.
What could go wrong
This is a small, single-country trial of 64 people, so any benefits may be modest or not hold up in larger studies. Mindful breathing is generally safe, but it may not change hard outcomes like ejection fraction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Oct 2023

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with NYHA Stage II or III heart failure * Have experienced heart failure symptoms * Aged 18 years or older * Able to read and write in Turkish * Able to use a smartphone, respond to daily researcher calls, and participate in WhatsApp video conferences Exclusion Criteria: * Diagnosed with NYHA Stage I or IV heart failure * Having physical or mental conditions that impair communication * Currently using non-pharmacological treatments such as herbal medicine, meditation, or yoga * Having health conditions that prevent breath awareness exercises (e.g., advanced asthma, advanced COPD)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure Mindful breathing meditation Nursing care Symptom management

Contacts and locations

Locations

  • Ankara Health Sciences University

    Ankara, Keçiören, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.